-
Mashup Score: 0Sarcopenia and aortic valve disease - 2 hour(s) ago
Valvular heart disease, including calcific or degenerative aortic stenosis (AS), is increasingly prevalent among the older adult population. Over the last few decades, treatment of severe AS has been revolutionised following the development of transcatheter aortic valve replacement (TAVR). Despite improvements in outcomes, older adults with competing comorbidities and geriatric syndromes have suboptimal quality of life outcomes, highlighting the cumulative vulnerability that persists despite valve replacement. Sarcopenia, characterised by loss of muscle strength, mass and function, affects 21%–70% of older adults with AS. Sarcopenia is an independent predictor of short-term and long-term outcomes after TAVR and should be incorporated as a prognostic marker in preprocedural planning. Early diagnosis and treatment of sarcopenia may reduce morbidity and mortality and improve quality of life following TAVR. The adverse effects of sarcopenia can be mitigated through resistance training and
Source: heart.bmj.comCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 0Sarcopenia and aortic valve disease - 11 hour(s) ago
Valvular heart disease, including calcific or degenerative aortic stenosis (AS), is increasingly prevalent among the older adult population. Over the last few decades, treatment of severe AS has been revolutionised following the development of transcatheter aortic valve replacement (TAVR). Despite improvements in outcomes, older adults with competing comorbidities and geriatric syndromes have suboptimal quality of life outcomes, highlighting the cumulative vulnerability that persists despite valve replacement. Sarcopenia, characterised by loss of muscle strength, mass and function, affects 21%–70% of older adults with AS. Sarcopenia is an independent predictor of short-term and long-term outcomes after TAVR and should be incorporated as a prognostic marker in preprocedural planning. Early diagnosis and treatment of sarcopenia may reduce morbidity and mortality and improve quality of life following TAVR. The adverse effects of sarcopenia can be mitigated through resistance training and
Source: heart.bmj.comCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 36Insuficiencia mitral aguda - 2 day(s) ago
Alcanzamos la infografía número treinta y nueva de la serie creada por el Dr. Edgardo Alania.
Source: Ecocardio.comCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 0Arrhythmogenesis in Fabry Disease - 2 day(s) ago
Current Cardiology Reports – Fabry Disease (FD) is a rare lysosomal storage disorder characterised by multiorgan accumulation of glycosphingolipid due to deficiency in the enzyme…
Source: link.springer.comCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 0Sarcopenia and aortic valve disease - 3 day(s) ago
Valvular heart disease, including calcific or degenerative aortic stenosis (AS), is increasingly prevalent among the older adult population. Over the last few decades, treatment of severe AS has been revolutionised following the development of transcatheter aortic valve replacement (TAVR). Despite improvements in outcomes, older adults with competing comorbidities and geriatric syndromes have suboptimal quality of life outcomes, highlighting the cumulative vulnerability that persists despite valve replacement. Sarcopenia, characterised by loss of muscle strength, mass and function, affects 21%–70% of older adults with AS. Sarcopenia is an independent predictor of short-term and long-term outcomes after TAVR and should be incorporated as a prognostic marker in preprocedural planning. Early diagnosis and treatment of sarcopenia may reduce morbidity and mortality and improve quality of life following TAVR. The adverse effects of sarcopenia can be mitigated through resistance training and
Source: heart.bmj.comCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 1Manifestations of Prosthetic Valve Endocarditis: Lessons From Multimodality Imaging and Pathological Correlation - 3 day(s) ago
Heart valve replacement has steadily increased over the past decades due to improved surgical mortality, an aging population, and the increasing use of transcatheter valve technology. With these deve
Source: www.ahajournals.orgCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 0Sarcopenia and aortic valve disease - 4 day(s) ago
Valvular heart disease, including calcific or degenerative aortic stenosis (AS), is increasingly prevalent among the older adult population. Over the last few decades, treatment of severe AS has been revolutionised following the development of transcatheter aortic valve replacement (TAVR). Despite improvements in outcomes, older adults with competing comorbidities and geriatric syndromes have suboptimal quality of life outcomes, highlighting the cumulative vulnerability that persists despite valve replacement. Sarcopenia, characterised by loss of muscle strength, mass and function, affects 21%–70% of older adults with AS. Sarcopenia is an independent predictor of short-term and long-term outcomes after TAVR and should be incorporated as a prognostic marker in preprocedural planning. Early diagnosis and treatment of sarcopenia may reduce morbidity and mortality and improve quality of life following TAVR. The adverse effects of sarcopenia can be mitigated through resistance training and
Source: heart.bmj.comCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 5Malignant Hypertension:A Systemic Cardiovascular Disease: JACC Review Topic of the Week - 4 day(s) ago
AbstractMalignant hypertension (MHT) is a hypertensive emergency with excessive blood pressure (BP) elevation and accelerated disease progression. MHT is characterized by acute microvascular damage…
Source: www.jacc.orgCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 1Measurement and Application of Incidentally Detected Coronary Calcium: JACC Review Topic of the Week - 4 day(s) ago
AbstractCoronary artery calcium (CAC) scoring is a powerful tool for atherosclerotic cardiovascular disease risk stratification. The nongated, noncontrast chest computed tomography scan (NCCT) has …
Source: www.jacc.orgCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 5Malignant Hypertension:A Systemic Cardiovascular Disease: JACC Review Topic of the Week - 4 day(s) ago
AbstractMalignant hypertension (MHT) is a hypertensive emergency with excessive blood pressure (BP) elevation and accelerated disease progression. MHT is characterized by acute microvascular damage…
Source: www.jacc.orgCategories: General Medicine News, Cardiologists1Tweet
https://t.co/crKnv9q5Gq